Vaamonde J, Luquin M R, Obeso J A
Department of Neurology, University of Navarra, Pamplona, Spain.
Mov Disord. 1990;5(3):260-2. doi: 10.1002/mds.870050316.
The aim of this study was to assess whether or not continuous infusion of lisuride in combination with intermittent levodopa-carbidopa administration was associated with tolerance. Intravenous apomorphine was given to four patients before initiation of chronic treatment with subcutaneous lisuride infusion and oral levodopa. The study was repeated under identical conditions after a mean of 18 months of treatment. In no case was the motor response induced by apomorphine infusion reduced as compared to baseline assessment. Choreic dyskinesias accompanying the "on" state were enhanced in all patients. These findings suggest that chronic continuous infusion of a dopamine agonist like lisuride, associated with oral levodopa, is not accompanied by tolerance or down-regulation of striatal dopaminergic receptors.
本研究的目的是评估持续输注利苏瑞肽联合间歇性给予左旋多巴-卡比多巴是否会产生耐受性。在开始皮下输注利苏瑞肽和口服左旋多巴的长期治疗之前,对4名患者给予静脉注射阿扑吗啡。在平均治疗18个月后,在相同条件下重复该研究。与基线评估相比,在任何情况下,阿扑吗啡输注诱导的运动反应均未降低。所有患者“开”期伴随的舞蹈样运动障碍均加重。这些发现表明,与口服左旋多巴联合使用时,像利苏瑞肽这样的多巴胺激动剂进行慢性持续输注不会伴随纹状体多巴胺能受体的耐受性或下调。